This is a opportunity to be a valuable contributor in a well-funded clinical company with field-leading advisors, best-in-class partners, and an experienced team currently advancing our lead program is amsoki-cel (OBX-115), a novel engineered tumor-infiltrating lymphocyte (TIL) cell therapy that uses our proprietary cytoDRiVE platform. Bachelor's degree in Biology, Immunology, Biotechnology, Cell Biology, Biomedical Engineering, or a related scientific discipline, with 1+ years of hands-on laboratory experience in an academic, biotechnology, or pharmaceutical research environment.